Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis
This study investigated women with symptomatic adenomyosis and found a correlation between dysmenorrhea severity and elevated uterine contractility alongside increased oxytocin receptor expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (70)
- Adenomyosis via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- A pilot study on the off-label use of valproic acid to treat adenomyosis via openalex
- Characteristics of uterine contractility during menses in women with mild to moderate endometriosis via openalex
- Constitutive and Tumor Necrosis Factor-Alpha-Stimulated Activation of Nuclear Factor-KappaB in Immortalized Endometriotic Cells and Their Suppression by Trichostatin A via openalex
- Contractility of the Nonpregnant Uterus via openalex
- Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA via openalex
- Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis via openalex
- Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids via openalex
- <i>Endometriosis and Tissue Factor</i> via openalex
- Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis via openalex
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 via openalex
- Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation via openalex
- Medical and surgical management of adenomyosis via openalex
- MYOMETRIAL PHYSIOLOGY AND ITS RELATION TO PELVIC PAIN via openalex
- Nerve fibers and menstrual cycle in peritoneal endometriosis via openalex
- Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts via openalex
- Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
- Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis via openalex
- Uterine contractility in patients with endometriosis via openalex
- Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin via openalex
- Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction via openalex
- Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis via openalex
- W2019291960 via openalex
- W2053695710 via openalex
- W2056686776 via openalex
- W2057382546 via openalex
- W2058170926 via openalex
- W2059968407 via openalex
- W2015363208 via openalex
- W1997359763 via openalex
- W2071386031 via openalex
- W1992638684 via openalex
- W2076236871 via openalex
- W1992297132 via openalex
- W2079078286 via openalex
- W1991677072 via openalex
- W2082317078 via openalex
- W2082993375 via openalex
- W2084634883 via openalex
- W2088426128 via openalex
- W2091815717 via openalex
- W1969527741 via openalex
- W2119515611 via openalex
- W2125338361 via openalex
- W2125836586 via openalex
- W2133292405 via openalex
- W1966712100 via openalex
- W2135575116 via openalex
- W2142818147 via openalex
- W2155438634 via openalex
- W2155528602 via openalex
- W2160280536 via openalex
- W2168161193 via openalex
- W2280693823 via openalex
- W2343952424 via openalex
- W2406102853 via openalex
- W2582743722 via openalex
- W1491294744 via openalex
- W4255986393 via openalex
- W6656495907 via openalex
- W2033232788 via openalex
- W7073538409 via openalex
- W2036411073 via openalex
- W2038354928 via openalex
- W2027951004 via openalex
Cited by (50)
- Hormonal basis of the pathological course of the first trimester of pregnancy in women with adenomyosis 2026
- Phenotypic heterogeneity in adenomyosis: internal and external subtypes 2025
- β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis 2025
- Experimental Models of Adenomyosis as the Basis for Developing New Methods in the Treatment of the Disease. Part II. Evaluation of the Effectiveness of Adenomyosis Treatment in Female Wistar Rats 2025
- Systematic review and meta‐analysis of adverse pregnancy outcomes with different types of adenomyosis 2025
- Drug development for adenomyosis based on pathophysiology 2025
- Efficacy of levonorgestrel releasing intrauterine system in the treatment of symptomatic adenomyosis: comparison with dienogest 2025
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Enhanced purification of uterine smooth muscle cells from adenomyosis using a novel dual-enzyme digestion method 2024
- Global Analysis of Transcription Start Sites and Enhancers in Endometrial Stromal Cells and Differences Associated with Endometriosis 2023
- Diagnosis, pelvic pain, and medication mediate cognitive empathic abilities among women with endometriosis or polycystic ovary syndrome 2023
- Are lower levels of apoptosis and autophagy behind adenomyotic lesion survival? 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Magnetic Resonance Imaging-guided Focused Ultrasound Surgery in a Swine Adenomyosis Model 2023
- The role of the junctional zone in the management of adenomyosis with infertility 2023
- A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment 2023
- Blood oxytocin levels and the rs4686302 polymorphism of the oxytocin receptor gene in patients with adenomyosis 2023
- Relation between adenomyosis and elastographic characteristics of the cervix 2023
- Differences clinical characteristics and factors in intrinsic and extrinsic adenomyosis 2023
- Psycho-emotional status in patients with endometriosis-associated pain syndrome in various disease phenotypes 2023
- Protective Effects of Resveratrol Against Adenomyosis in a Mouse Model 2023
- Insights on Adenomyosis Development 2022
- Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis 2022
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- Adenomyosis; Diagnosis, Clinical Findings and Current Approaches to Treatment 2022
- The Performance of the Uterine Artery Resistance Index following Stimulation of the Cervix in the Diagnosis of Endometriosis: A Prospective Study 2022
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health 2022
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- Transcriptomic analysis supports collective endometrial cell migration in the pathogenesis of adenomyosis 2022
- The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis 2021
- Estrogen 17β‑estradiol accelerates the proliferation of uterine junctional zone smooth muscle cells via the let‑7a/Lin28B axis in adenomyosis 2021
- “Endometriosis-Like Syndrome”: from the concept of Painful Uterine Syndrome to the use of Myometrial Botulinum Toxin injections under hysteroscopy. 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model 2020
- Oxytocinergic regulation in pathogenesis of pelvic pain caused by adenomyosis 2020
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis 2020
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis 2020
- The importance of the junctional zone of the endometrium in human reproduction 2020
- Current and Future Medical Therapies for Adenomyosis 2020
- Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study 2020
- Pathology and Pathogenesis of Adenomyosis 2020
- Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis 2020
- Physiomimetic Models of Adenomyosis 2020
- The role of oxytocin in the pathogenesis of endometriosis: various aspects of the problem 2019
- Faculty Opinions recommendation of Complications and outcomes of pregnant women with adenomyosis in Japan. 2019
- Rethinking mechanisms, diagnosis and management of endometriosis 2019
- Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis 2019
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:04.919516+00:00